Jia Liu, Jia Liu, Lidan Cao, Lidan Cao, Jing Wu, & Jing Wu. (2022). Corrigendum: Cost-utility analysis of lurasidone for the first-line treatment of schizophrenia in China. Frontiers Media S.A..
Chicago Style (17th ed.) CitationJia Liu, Jia Liu, Lidan Cao, Lidan Cao, Jing Wu, and Jing Wu. Corrigendum: Cost-utility Analysis of Lurasidone for the First-line Treatment of Schizophrenia in China. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationJia Liu, et al. Corrigendum: Cost-utility Analysis of Lurasidone for the First-line Treatment of Schizophrenia in China. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.